Cargando…
Thyroid cancer in the Era of COVID-19
The recent coronavirus infectious disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is placing health systems in serious challenges worldwide. Shocking statistics each day has prompted the World Health Organization to officially declare the COVID-19 outbreak a...
Autores principales: | Smulever, Anabella, Abelleira, Erika, Bueno, Fernanda, Pitoia, Fabián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402074/ https://www.ncbi.nlm.nih.gov/pubmed/32754886 http://dx.doi.org/10.1007/s12020-020-02439-6 |
Ejemplares similares
-
Active surveillance in low risk papillary thyroid carcinoma
por: Pitoia, Fabian, et al.
Publicado: (2020) -
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America
por: Smulever, Anabella, et al.
Publicado: (2019) -
Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
por: Smulever, Anabella, et al.
Publicado: (2023) -
New approaches for patients with advanced radioiodine-refractory thyroid cancer
por: Pitoia, Fabián, et al.
Publicado: (2022) -
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience
por: Bueno, Fernanda, et al.
Publicado: (2023)